Disease | progressive multifocal leukoencephalopathy |
Comorbidity | C0024141|systemic lupus erythematosus |
Sentences | 2 |
PubMedID- 24194647 | The most significant error pertains to a statement made within the safety section, which states: “serious adverse effects (aes) included pathological liver function, neutropenia, and trigeminal neuralgia as well as one case of progressive multifocal leukoencephalopathy (pml) in a patient with systemic lupus erythematosus.” we would like to draw the authors’ attention to the fact that this case of pml pertains to the use of the related drug, leflunomide, and not teriflunomide as suggested. |
PubMedID- 22687798 | Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. |
Page: 1